Canadian Solar Reports Third Quarter 2024 Results

Canadian Solar Reports Third Quarter 2024 Results

KITCHENER, ON, Dec. 5, 2024 /PRNewswire/ -- Canadian Solar Inc. ("Canadian Solar" or the "Company") (NASDAQ: CSIQ) today announced financial results for the third quarter ended September 30, 2024. Highlights 16.4% gross margin, above guidance of 14%...

Starpay Partners with OceanBase to Enhance Database System

Starpay Partners with OceanBase to Enhance Database System

MANILA, Philippines, Dec. 5, 2024 /PRNewswire/ -- Starpay, a leading financial technology company in the Philippines, today announced its partnership with OceanBase to leverage the power of OceanBase's industry-leading distributed database...

Cutting-Edge Industrial Cluster Lights Up Northern Vietnam: A New Map of Opportunities Emerges

Cutting-Edge Industrial Cluster Lights Up Northern Vietnam: A New Map of Opportunities Emerges

RSQUARE Vietnam Analysis: "Bac Ninh-Bac Giang-Hung Yen Industrial Belt Rising as a New Hub for Global Enterprises" Industrial Park Prices Up by 7% YoY; Rental Rates for Factories Also Soaring RSQUARE Vietnam to Host Investment Seminar on December 17...

Korea Legal Industry Veteran Robert Surh Joins TransPerfect Legal

Korea Legal Industry Veteran Robert Surh Joins TransPerfect Legal

NEW YORK and SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- TransPerfect Legal, the global leader in legal technology, AI, and advisory services, today announced the hiring of Robert Surh as a Director in the company's APAC region. Based in Seoul,...

Coles Group Chooses Stibo Systems to Help Improve its Customer Experience Across Digital Channels

Coles Group Chooses Stibo Systems to Help Improve its Customer Experience Across Digital Channels

MELBOURNE, Australia, Dec. 5, 2024 /PRNewswire/ -- Coles Group, a leading Australian retailer, announced the successful go-live of its master data management (MDM) solution in partnership with Stibo Systems. The new system, powered by Stibo Systems'...

ReTo Secured Production Line Contract with Middle Eastern Client

ReTo Secured Production Line Contract with Middle Eastern Client

BEIJING, Dec. 4, 2024 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a provider of technology solutions and operation services for intelligent ecological environments and Internet of Things technology development...

China NMPA approves Simcere's Sanbexin® sublingual tablets for the treatment of Acute Ischemic Stroke

China NMPA approves Simcere's Sanbexin® sublingual tablets for the treatment of Acute Ischemic Stroke

NANJING, China, Dec. 4, 2024 /PRNewswire/ -- On November 2, 2024, Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets), an innovative drug for stroke, has been approved for...

PEARSON ENGLISH LANGUAGE TEACHING AWARD WINNER ONE OF 12,000 TEACHERS HELPING INDONESIAN GOVERNMENT LIFT ENGLISH PROFICIENCY

PEARSON ENGLISH LANGUAGE TEACHING AWARD WINNER ONE OF 12,000 TEACHERS HELPING INDONESIAN GOVERNMENT LIFT ENGLISH PROFICIENCY

JAKARTA, Indonesia, Dec. 4, 2024 /PRNewswire/ -- Pearson (LON: PSON), the world's leading learning company, today announced Ulfa Rafiqha has achieved a Silver in the Pearson English Language Teacher Awards. She is one of 12,000 teachers who just...

Akeso's Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Combination Therapy for PD-(L)1 Resistant NSCLC Showcased in Oral Presentation at 2024 Asian Conference on Lung Cancer

Akeso's Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Combination Therapy for PD-(L)1 Resistant NSCLC Showcased in Oral Presentation at 2024 Asian Conference on Lung Cancer

HONG KONG, Dec. 4, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the results from a prospective, open-label, single-arm, multi-center phase Ib/II clinical study (AK104-IIT-018) of cadonilimab (PD-1/CTLA-4 bispecific...

Duality Biologics and GSK Enter Exclusive Option Agreement for a Novel Antibody-drug Conjugate (DB-1324)

Duality Biologics and GSK Enter Exclusive Option Agreement for a Novel Antibody-drug Conjugate (DB-1324)

PRINCETON, N.J., SHANGHAI and SUZHOU, China, Dec. 4, 2024 /PRNewswire/ -- Duality Biologics ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next-generation antibody-drug conjugate (ADC) therapeutics,...

  • 1
  • ...
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • ...
  • 90
  • menu
    menu